Plus Therapeutics amends bylaws to reflect corporate name change to Cerenome

Plus Therapeutics has amended its bylaws to officially change its corporate name to Cerenome, effective August 3, 2026. Concurrently, the company's Nasdaq trading symbol will switch from PLSR to CNSY on that date. The CUSIP for common stock remains unchanged. This announcement was filed via EDGAR.

Plus Therapeutics amended its bylaws to reflect a corporate name change to Cerenome, effective Aug. 3, 2026. * Nasdaq trading symbol switched to CNSY at the start of trading on Aug. 3, 2026. * CUSIP for the common stock remains unchanged. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-332939), on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here